FORM OF REGISTRATION RIGHTS AGREEMENT by and among the Persons listed on Schedule A hereto, and CureVac N.V. Dated as of [●], 2020Registration Rights Agreement • August 7th, 2020 • CureVac B.V. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT, dated as of [●], 2020 (as it may be amended supplemented or otherwise modified from time to time, this “Agreement”), is made among CureVac N.V., a Dutch public limited liability company (naamloze vennootschap) incorporated under the law of the Netherlands (the “Company”) and the persons listed on Schedule A hereto (each such Person, a “Holder”). Capitalized terms used in this Agreement without definition have the meaning set forth in Section 1.
FIRST AMENDMENT AND JOINDER TO GLOBAL ACCESS COMMITMENTS AGREEMENTGlobal Access Commitments Agreement • August 7th, 2020 • CureVac B.V. • Pharmaceutical preparations • New York
This FIRST AMENDMENT AND JOINDER TO GLOBAL ACCESS COMMITMENTS AGREEMENT ("Agreement") is dated as of the 15th day of July, 2020, by and among the Bill & Melinda Gates Foundation, a Washington charitable trust that is a tax-exempt private foundation (the "Foundation"), CureVac AG, a stock corporation incorporated in Germany ("CureVac AG"), and CureVac B.V., a Dutch private company with limited liability ("CureVac BV", or after its change of legal form as described below, "CureVac NV").
REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. SECOND AMENDMENT TO GLOBAL ACCESS COMMITTMENTS...Global Access Commitments Agreement • August 7th, 2020 • CureVac B.V. • Pharmaceutical preparations • New York
This FIRST AMENDMENT TO GLOBAL ACCESS COMMITMENTS AGREEMENT ("Agreement") is effective as of the 15th day of July, 2020, by and among the Bill & Melinda Gates Foundation, a Washington charitable trust that is a tax-exempt private foundation (the "Foundation") and CureVac AG, a German stock corporation (the "Company").
